ARCHIVES

Immunotherapy Demonstrates Disease Control in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

Other DCT Concepts Approved By BSC

June 6, 1986

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997

Lurie Center At Northwestern Wins Core Grant Renewal.

December 7, 2001

Arizona First To Get Comprehensive Recognition Under New Guidelines; salmon Names Alberts As His Deputy, With Trent Going To Michigan

March 16, 1990